Follow the Caplin Point Laboratories Limited share price and the full insider trade history of the company, a listed issuer based in India. Shares trade on IN IN, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Caplin Point Laboratories Limited has published 38 reports. Market capitalisation: €156bn. The latest transaction was reported on 23 March 2023 (Purchase). Among the most active insiders: Arulsudar Natrajan. All data is accessible without an account.
38
Insider Decl.
0
Thresholds
€6m
32 ops.
Buy Volume
€149,936
6 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Caplin Point Laboratories Limited Strong Buy (bullish), based on 2 analysts. Average price target: ₹2,505.00.
10Σ signal
Buys €6m€149,936 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 3,915 of 25,750 companies
69.9
score / 100
Value
54
Quality
86
FCF yld1.8%
Earn yld4.1%
EV/EBITDA·
ROE20%
Gross mgn60%
Net mgn29%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.